Background: Migraine is associated with various types of stigma. This study aims to evaluate stigmatizing attitudes towards people with migraine by people without active migraine.

Methods: OVERCOME (US) was a web survey among adults from a representative US population-based sample that collected information about stigmatizing attitudes of people without active migraine (i.e., no migraine/severe headaches in the previous 12 months) toward people with migraine and related conditions. The following associations were examined in the current analysis: (1) association between stigma toward migraine and relationship to people with migraine, (2) association between stigma toward migraine and sex, and (3) association between stigma toward migraine and historical headache/migraine status. We further compared stigmatizing attitudes toward people with migraine compared to people with chronic low back pain and epilepsy.

Results: In this observational, population-based study, a total of 11,997 respondents without active migraine were queried about attitudes and beliefs about people with migraine. With a mean age of 47.4 (standard deviation 17.3) years, the majority of the respondents were female (51.1%), White (75.6%), and non-Hispanic (82.3%). Nearly 70% of people queried endorsed ≥ 1 stigmatizing attitude from eleven possibilities. Stigmatizing attitudes and beliefs were more prevalent among those with a closer relationship to someone with migraine (family or friend) or those who knew multiple people with migraine, in particular among those who felt personally impacted by knowing a family member or co-worker/supervisor/employee with migraine or severe headache. Respondents with prior migraine endorsed more stigmatizing attitudes than those without migraine/headache history. Lastly, the analysis showed that stigmatizing attitudes toward people with migraine were much more prevalent than those toward people with epilepsy and similar to those toward people with chronic low back pain.

Conclusions: Stigma towards people with migraine is widespread but surprisingly more common the closer the relationship(s) to a person/persons with migraine and in those who have experienced migraine themselves. Raising awareness about the stigma towards people with migraine that exists in public may help people with migraine feel more confident to advocate for themselves and seek care, as well as creating more public and social support for accommodations, research funding, and treatment.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12883-025-04039-1DOI Listing

Publication Analysis

Top Keywords

people migraine
44
stigmatizing attitudes
28
migraine
23
attitudes people
20
people
18
people active
12
active migraine
12
association stigma
12
stigma migraine
12
stigmatizing
8

Similar Publications

Salivary Metabolomics as a Diagnostic Tool: Distinct Metabolic Profiles Across Orofacial Pain Subtypes.

Int J Mol Sci

March 2025

Department of Oral Medicine, Sedation and Imaging, Hadassah Medical Center, Faculty of Dental Medicine, Hebrew University of Jerusalem, P.O. Box 12272, Jerusalem 91120, Israel.

Orofacial pain (OFP) includes chronic pain conditions categorized into musculoskeletal (MS), neurovascular (NV), and neuropathic (NP) pain types, encompassing temporomandibular disorders (TMD), migraines, trigeminal neuralgia (TN), post-traumatic neuropathies, and burning mouth syndrome (BMS). These conditions significantly affect quality of life; yet, their underlying metabolic disruptions remain inadequately explored. Salivary metabolomics provides a non-invasive method to investigate biochemical alterations associated with OFP subtypes.

View Article and Find Full Text PDF

Background: Migraine is associated with various types of stigma. This study aims to evaluate stigmatizing attitudes towards people with migraine by people without active migraine.

Methods: OVERCOME (US) was a web survey among adults from a representative US population-based sample that collected information about stigmatizing attitudes of people without active migraine (i.

View Article and Find Full Text PDF

Background: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder associated with progressive loss of motor neurons, this result in muscle denervation, atrophy and consequently death takes place due to respiratory failure within 3-5 years of onset of symptoms.

Our Aim: Was to investigate types and frequency of headache in ALS patients.

Methods: This is cross sectional hospital based study.

View Article and Find Full Text PDF

Introduction: Primary headaches pose a significant burden on children and adolescents, highlighting the need for effective non-pharmacological interventions. Transcutaneous auricular vagus nerve stimulation (taVNS) is a non-invasive modality that has demonstrated efficacy in adult populations with primary headaches and has shown safety in adolescents with mental health disorders. However, its effectiveness in managing acute headache episodes and preventing recurrences in paediatric populations remains underexplored.

View Article and Find Full Text PDF

Background: Real-world data on the long-term adherence to- and efficacy of fremanezumab 675 mg quarterly dosing remain scarce. Our study evaluated the efficacy of- and patient adherence to 675 mg fremanezumab for episodic migraine (EM) and chronic migraine (CM) over 2 years and analyzed the reasons for discontinuation.

Methods: Among patients attending our headache outpatient clinic, those aged ≥ 15 years who commenced fremanezumab 675 mg quarterly dose schedule from November 2021 to June 2022 were enrolled in this single-center observational study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!